Emricasan(NOBO Medicine)

N/A

Report date: 2025/10/24 17:59:51

First In Class

Base Information

Drug NameEmricasan(NOBO Medicine)

Drug Alias NameProject 101Project 102

ClassificationSmall molecules

Mechanisms of ActionCaspase inhibitorsApoptosis inhibitors

TargetsCaspase

Therapy Area/IndicationsCardiovascular DiseasesGeographic Atrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNOBO Medicine Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCardiovascular DiseasesGeographic Atrophy

Inactive IndicationsN/A

ATC CodeN/A